Accessibility Menu
Haleon Plc logo

Haleon Plc(NYSE) HLN

Market Cap$42.72BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.
Since IPO (2022)+38%
5 YearN/A
1 Year+3%
1 Month+0%
$9.71
-0.32%
-0.03Today
After hours$9.71+$0.00 (+0.00%)
Haleon Plc last closing stock price
MetricPriceDate
Last closeUSD 9.702026-08-14
Haleon Plc stock price return by period
PeriodPrice returnPrice at period startPeriod start date
1 week-2.65%USD 9.962026-08-07
1 month+0.14%USD 9.692026-07-15
3 month+8.97%USD 8.902026-05-15
Year to date-2.12%USD 9.912025-12-31
1 year+2.65%USD 9.452025-08-14
3 year+20.48%USD 8.052023-08-15
Since inception+38.34%USD 7.012022-07-18

Haleon Plc Financials at a Glance

Market Cap

$42.72BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Revenue (TTM)

£19.38B

Net Income (TTM)

£2.83B

EPS (TTM)

$0.49

P/E Ratio

19.85

Dividend

$0.26

Beta (Volatility)

0.16 (Low)

Price

$9.71

Volume

3,292,218.193

Open

$9.73

Previous Close

$9.70

Daily Range

$9.67 - $9.75

52-Week Range

$8.65 - $11.28

Estimated Earnings Date

Mar 4, 2027

HLN News

Pills on money

How to Buy Novo Nordisk Stock (NVO): Step-by-Step & What to Expect

Matt DiLalloJul 29, 2026

HLN: Motley Fool Moneyball Superscore

64

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Haleon Plc

Haleon plc is a prominent global player in the consumer healthcare sector, focusing on the research, development, production, and distribution of wellness products. Established in 2021, the company offers a diverse range of therapeutic solutions and dietary supplements across multiple regions, including North America, Europe, and Asia Pacific.

Products and Services
  • Therapeutic solutions for oral care, pain management, and respiratory health
  • Vitamins, minerals, and dietary supplements
  • Notable brands include Panadol, Voltaren, and Sensodyne
Growth Outlook
  • Revenue of £5.52 billion reported in Q4 2025, showing consistent growth
  • Net income of £855.69 million in Q4 2025, reflecting strong profitability
  • Operating income margin of 22.67% indicates efficient cost management
Financial Highlights
  • Trailing twelve-month revenue of £21.5 billion, demonstrating robust market demand
  • Dividend yield of 1.90%, appealing for income-focused investors
  • Net profit margin of 15.11% highlights effective operational efficiency
Haleon plc operates in a competitive landscape, yet its strong brand portfolio and commitment to innovation position it well for future growth. The company's focus on consumer health aligns with increasing global health awareness, making it a compelling option for investors interested in the healthcare sector. Recent financial performance underscores its ability to generate substantial revenue and maintain profitability, further enhancing its attractiveness as a potential investment opportunity.
AI Generated • Jul 19, 2026

Industry

Pharmaceuticals

Sector

Health Care

CEO

Brian James McNamara, MBA

Website

www.haleon.com

Headquarters

Weybridge, KT13 0NY, GB

HLN Financials

Key Financial Metrics (TTM)

Gross Margin

65.57%

Operating Margin

21.35%

Net Income Margin

14.55%

Return on Equity

9.89%

Return on Capital

9.65%

Return on Assets

4.98%

Earnings Yield

5.04%

Dividend Yield

2.65%

Payout Ratio

39.00%

Stock Overview

Market Cap

$42.72BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

Shares Outstanding

4.40B

Volume

3.29M

Avg. Volume

9.50M

Financials (TTM)

Gross Profit

£12.62B

Operating Income

£4.40B

EBITDA

£5.01B

Operating Cash Flow

£3.52B

Capital Expenditure

-£434.44M

Free Cash Flow

£3.08B

Cash & ST Invst.

£821.01M

Total Debt

£8.20B

Haleon Plc Performance Analysis

Haleon Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal yearPeriod endRevenueYoY growth
20222022-12-31GBP 13,374,669,1971.9%
20232023-12-31GBP 14,048,971,9195.0%
20242024-12-31GBP 14,353,665,6892.2%
20252025-12-31GBP 14,536,329,5781.3%
Haleon Plc sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-03-31-50.5%
Q22025-06-30100.0%
Q42025-12-31N/A
Q22026-06-30N/A
Haleon Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal yearPeriod endDiluted EPSYoY growth
20222022-12-31GBP 0.28-31.7%
20232023-12-31GBP 0.28-0.4%
20242024-12-31GBP 0.4042.6%
20252025-12-31GBP 0.4921.2%
Haleon Plc sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarterPeriod endQoQ growth
Q12025-03-31-42.9%
Q22025-06-30100.0%
Q42025-12-31N/A
Q22026-06-30N/A

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

£5.64B

+1.9%

Gross Profit

£3.73B

+9.6%

Gross Margin

66.05%

N/A

Market Cap

$42.72BMarket cap calculated using publicly traded shares outstanding only. Does not include unlisted, private, or dual-class non-traded shares. Implied market cap may vary.

N/A

Market Cap/Employee

$1.74M

N/A

Employees

24,535

N/A

Net Income

£767.62M

+7.2%

EBITDA

£1.52B

+19.9%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Total Cash

£821.01M

+54.6%

Total Debt

£8.20B

-7.4%

Accounts Receivable

£2.33B

+9.3%

Inventory

£1.06B

-27.2%

Long Term Debt

£6.25B

-15.6%

Short Term Debt

£1.95B

+34.4%

Return on Assets

4.98%

N/A

Return on Invested Capital

9.04%

N/A

Free Cash Flow

£791.80M

N/A

Operating Cash Flow

£902.61M

N/A

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
AAgilent Technologies, Inc.
$148.55-0.49%
IQVIQVIA Holdings Inc.
$236.66-2.01%
HUMHumana Inc.
$389.05+1.06%
ALCAlcon Inc.
$74.25+0.99%

Trending Stocks

Symbol / CompanyPricePrice Chg
NUNu Holdings
$15.23+0.09%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF
$8.76+0.01%
ONDSOndas
$9.24+0.04%
SPCXSpace Exploration Technologies
$140.00-0.01%

Questions About HLN

What is the current price of Haleon Plc?

Haleon Plc is trading at $9.70 per share.

What is the 52-week range for Haleon Plc?

Over the past 52 weeks, Haleon Plc has traded between $8.65 and $11.28.

How much debt does Haleon Plc have?

As of the most recent reporting period, Haleon Plc reported total debt of £11.58B.

How much cash does Haleon Plc have on hand?

Haleon Plc reported £1.78B in cash and cash equivalents in its most recent financial results.

What is Haleon Plc’s dividend yield?

Haleon Plc currently has a dividend yield of 2.65%.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.

View Premium Services